GTHCX Mutual Fund

GTHCX Mutual Fund

NAV$18.78
See how much of GTHCX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing the top 10 of 81 holdings · as of Mar 31, 2026
Top 10 weight
42.62%
GTHCX top 10 holdings, by weight
#TickerNameWeightCumulativeSectorIndustry
1
LLY
Eli Lilly & Co.Health Care · Pharmaceuticals
9.07%		9.1%Health CarePharmaceuticals
2
JNJ
Johnson & Johnson -Health Care · Pharmaceuticals
5.81%		14.9%Health CarePharmaceuticals
Sector and industry · Pro
3—AstraZeneca PLC
4.34%		19.2%
4
GILD
Gilead Sciences
4.10%		23.3%
5
ABBV
AbbVie Inc.
3.67%		27.0%
6
COR
Cencora Inc
3.65%		30.6%
7
MCK
Mckesson Corp
3.59%		34.2%
8—Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
3.37%		37.6%
9DebtInvesco Treasury Portfolio
2.75%		40.4%
10
MRK
Merck & Company Inc
2.27%		42.6%
More holdings · Pro
FundXLS Pro
See the other 71 holdings of GTHCX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime
Themes in the top 10
PharmaceuticalsBiotechnologyMedical DevicesImmunologyOncologyAsset ManagementInvestment TechnologyMarket InfrastructureGlobal BankingInterest RatesSupply ChainLife Sciences ToolsBiotechnology ToolsSemiconductorsAging Population

GTHCX Mutual Fund Top Holdings

GTHCX holdings top 10 positions. The top 10 holdings account for 42.6% of the fund, led by Eli Lilly & Co. at 9.1%, Johnson & Johnson - Common at 5.8%, AstraZeneca PLC at 4.3%.

GTHCX portfolio concentration is moderate, with the top 10 representing 42.6% of total assets. The largest sector exposure is Health Care at 82.6%.

GTHCX sectors provide a detailed breakdown. GTHCX overlap shows how holdings compare to other funds in your portfolio.